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Abstract
Introduction: The emergency laboratory in Hacettepe University Hospitals receives specimens from emergency departments (EDs), inpatient servi-
ces and intensive care units (ICUs). The samples are accepted according to the rejection criteria of the laboratory. In this study, we aimed to evaluate 
the sample rejection ratios according to the types of pre-preanalytical errors and collection areas.
Materials and methods: The samples sent to the emergency laboratory were recorded during 12 months between January to December, 2013 in 
which 453,171 samples were received and 27,067 specimens were rejected. 
Results: Rejection ratios was 2.5% for biochemistry tests, 3.2% for complete blood count (CBC), 9.8% for blood gases, 9.2% for urine analysis, 13.3% 
for coagulation tests, 12.8% for therapeutic drug monitoring, 3.5% for cardiac markers and 12% for hormone tests. The most frequent rejection 
reasons were fibrin clots (28%) and inadequate volume (9%) for biochemical tests. Clotted samples (35%) and inadequate volume (13%) were the 
major causes for coagulation tests, blood gas analyses and CBC. The ratio of rejected specimens was higher in the EDs (40%) compared to ICUs (30%) 
and inpatient services (28%). The highest rejection ratio was observed in neurology ICU (14%) among the ICUs and internal medicine inpatient ser-
vice (10%) within inpatient clinics. 
Conclusions: We detected an overall specimen rejection rate of 6% in emergency laboratory. By documentation of rejected samples and periodic 
training of healthcare personnel, we expect to decrease sample rejection ratios below 2%, improve total quality management of the emergency 
laboratory and promote patient safety. 
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Precision, accuracy, and short turnaround time 
(TAT) are important in effective emergency labora-
tory services. The types of laboratory errors are 
classified as preanalytical, analytical, and postana-
lytical, depending upon the time of presentation. 
Laboratory specialists have been demonstrated 
that 70% of errors occur in the preanalytical phase 
which is an important component of laboratory 
medicine (1,2). The International Organization for 
Standardization (ISO) 15189:2012 standard for lab-
oratory accreditation defines the preanalytical 
phase as “processes that start, in chronological or-
der, from the clinician’s request and include the 
examination request, preparation and identifica-
tion of the patient, collection of the primary 
sample(s), and transportation to and within the 
laboratory, and end when the analytical examina-
tion begins” (3). 
Plebani et al. (4,5) states that the preanalytical 
phase should be subdivided into pre-preanalytical 
phase and preanalytical phase. Pre-preanalytical 
phase includes test request, patient or sample 
identification, sample collection, handling and 
transport, whereas preanalytical phase involves 
the steps of sample preparation for analysis such 
as centrifugation, aliquoting and sorting. It has 
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been demonstrated that most errors occur in the 
pre-preanalytical phase by healthcare personnel 
who are not under the control of the laboratory, 
whereas preanalytical phase starts following spec-
imen acceptance by the laboratory staff. For the 
prevention of preanalytical errors, the most relia-
ble approach is to construct preanalytical stand-
ardization (6). 
Quality in laboratory medicine has been defined 
as the guarantee that each single step throughout 
the total testing process (TTP) is correctly per-
formed (7). Due to the improvements in analytical 
techniques and instrumentation, a 10-fold reduc-
tion in the analytical error rate has been achieved 
in the past decades. However, the preanalytical er-
rors have been found to be much more vulnerable 
in the TAT (8). Traditionally, preanalytical phase er-
rors were classified as identification errors and 
sample problems. The IFCC (International Federa-
tion of Clinical Chemistry and Laboratory Medi-
cine) working group of ‘Laboratory Errors and Pa-
tient Safety’ (WG-LEPS) has identified several Qual-
ity Indicators (QIs) related with all stages of the 
TTP; preanalytical phase quality indicators include 
the appropriateness of test selection, patient/sam-
ple identification, samples collected in inappropri-
ate containers or with insufficient volumes, 
hemolyzed or clotted samples, improperly stored 
samples or samples damaged in transport (9-11). 
Shortening turn-around-time (TAT) is one of the 
quality indicators in emergency laboratories. We 
hypothesized that the improvement in TAT is relat-
ed with correct pre-preanalytical phase procedure; 
receiving the appropriate sample from the right pa-
tient on time is necessary to achieve reliable labora-
tory results and promote patient safety. Hence, the 
aim of the study was to evaluate the sample rejec-
tion ratios (SRRs) at the emergency laboratory of 
Hacettepe University hospitals, to determine the 
types and frequencies of preanalytical errors and 
plan improvements in patient outcomes.
Materials and methods
In this study, the data about the samples sent to 
the emergency laboratory during 12 months from 
January 01 to December 31, 2013 was evaluated. 
For this study, the laboratory data was retrieved 
from the intra-institutional laboratory information 
system (LIS, LAB Asistan 2.0, TENAY) which is con-
nected to HIS (hospital information system). 
Laboratory setting
Hacettepe University Hospitals is one of the larg-
est university teaching hospital in Turkey with 
1000-bed capacity consisting of the Adult Hospital 
and Children’s Hospital. A total of approximately 
980,000 samples were performed per year in the 
clinical pathology laboratory and 45% of these 
tests were run in the emergency laboratory, which 
operates with independent staff for 24 hours, 7 
days a week, receiving samples from inpatient ser-
vices, intensive care units (ICUs), adult and pediat-
ric emergency departments (ED). The variable 
work shift is categorized into 2 groups as day (8:30 
AM to 4:30 PM) and night (4:30 PM to 8:30 PM); 
seven laboratory technician works at day shift and 
four works at night shift. Additionally, two special-
ized laboratory secretary for daytime and one for 
night shift, receive samples and decide to accept 
or reject samples according to the rejection crite-
ria of our laboratories as given in Table 1. The sec-
retaries were trained 1 week to specialize on rejec-
tion criteria and the training program was updat-
ed every 6 months by laboratory specialists. 
Sample rejection criteria of the emergency laboratory
•	 Improper test requests (incomplete, duplicate, errors in 
test input, inconsistent information)
•	 Inappropriate transport (transport temperature, light 
exposure, delayed transport time)
•	 Specimens without barcodes or unsuitable barcodes
•	 Misidentification (unlabeled, mislabeled or mismatched 
samples)
•	 Improper container or tube (including precious samples 
such as cerebrospinal fluid)
•	 Insufficient specimen volume (inappropriate blood/
anticoagulant ratio)
•	 Incorrect preservation, storage
•	 Lipemic specimen
•	 Hemolyzed specimen
•	 Clotted samples with fibrin
Table 1. The rejection criteria of the emergency laboratory. 
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All of the samples are hand delivered to the emer-
gency laboratory in which 23 analyzers are used: 2 
clinical chemistry analyzer (Beckman Coulter 
AU680 chemistry system), 1 immunoassay systems 
(ADVIA Centaur CP), 2 hemostasis analyzer (Sie-
mens BCS XP system), 2 chemistry analyzers for 
therapeutic drug monitoring (Roche Integra 400), 
2 hematology analyzer (Beckman Coulter LH780), 
2 automated sedimentation rate analyzer (ALI-
FAX), 3 blood gas analyzers (Siemens RAPIDLab 
1200), 2 urine chemistry (Beckman Coulter Iris 
urine analyzer), 1 automated blood culture system 
(Biomerieux BACT/ALLERT 3D), 1 lithium analyzer 
(Medica Easy Light Electrolyte Analyzer), 1 os-
mometer (Advanced Instruments 3320) and 1 
spectrophotometer (Schimadzu UVmini-1240). The 
range of tests performed in emergency laboratory 
includes biochemical tests, electrolytes, complete 
blood count (CBC), osmolality (serum, urine), car-
diac markers (myoglobin, CK-MB, troponin I, B-
type natriuretic peptide), coagulation panel (PT, 
aPTT, fibrinogen, D-dimer), therapeutic drug mon-
itoring (TDM), hormones (beta-hCG, TSH, free T4 
and T3), ethanol, arterial blood gases, urinalysis, 
anemia panel (ferritin, iron, folate, vitamin B12), 
ammonia, pyruvate, blood bank laboratory testing 
(hepatitis markers, HIV) and microbiology cultures 
(blood, urine, cerebrospinal fluid, body fluids, etc.). 
All of the emergency tests are available 24 hours a 
day on a priority basis. 
Sample identification
In Hacettepe University Hospitals, the patients are 
assigned a permanent hospital number and their 
medical information is entered into the hospital 
information system (HIS), an electronic version of 
the Personal Electronic Health Records containing 
physician notes, pathology diagnoses, radiology, 
and clinical laboratory results. Each biological 
sample taken from the patient to be analyzed in 
the laboratory is labeled with a barcode number; 
heated barcodes with 9 digits (code 39) are used 
for internal barcoding system to identify the name, 
surname, gender, age, the type of the tube, sam-
ple type, barcode print time, sample collection 
time and date, the site of service where the speci-
mens were collected, the list of the requested 
tests, the name of the doctor who requested the 
tests and the phlebotomist who collected the 
blood. Access to the databases is tightly moni-
tored and is restricted to clinical staff and labora-
tory members. The data related to microbiology 
cultures and blood bank laboratory testing were 
not included into the study, as they are under the 
control of microbiology department. 
The unsuitable samples were recognized and 
identified upon their arrival in the laboratory, by a 
simple visual inspection by the laboratory secre-
tary. Serum indices (hemolysis (H), lipemia (L) and 
Icterus (I) - LIH) were also measured. Samples that 
have been rejected are stored in the laboratory for 
up to 24 hours at 4 °C, a report is immediately is-
sued through the laboratory information system 
(LIS) stating that the sample has not been pro-
cessed. When precious specimens such as cere-
brospinal fluid (CSF) samples, biopsies (bone mar-
row etc.) or aspirates are received in unsuitable 
tubes or transported under inappropriate condi-
tions, the laboratory medicine specialists are re-
sponsible for deciding if the sample should be re-
jected or accepted. 
Sample rejection ratios (SRRs) were calculated ac-
cording to different test groups (biochemistry, 
CBC, blood gases, coagulation, TDM, cardiac mark-
ers, hormones and anemia panel) and analyzed ac-
cording to the site of services (ED, ICU, inpatient 
services). The distribution frequencies between 
the point of collection and the specimen rejec-
tions were evaluated by descriptive statistical anal-
yses (Microsoft Excel).
Results
The emergency laboratory of Hacettepe Universi-
ty Hospitals received 453,171 samples and rejected 
27,067 samples, and performed 8,979,918 tests in 
2013. Out of the total number of rejected samples, 
41% of rejected samples were coming from ED 
(31% from adult ED and 10% from pediatric ED), 
31% from ICUs and 28% from inpatient services 
(Figure 1A).
When all of the services were compared, the high-
est specimen rejection ratio was observed in adult 
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Figure 1. Sample rejection ratios (SRRs) according to sample 
collection areas A) In emergency departments (ED) (adult ED 
and pediatric ED, in total), intensive care units (ICUs) and inpa-
tient services B) In non-surgical and surgical intensive care units 
(ICUs).
Table 2. Quality indicators of the preanalytical phase proposed by the IFCC Working Group - Laboratory Errors and Patient Safety 
(IFCC WG-LEPS) and sample rejection ratios (SRRs) in the emergency laboratory of Hacettepe University.
Quality Indicators of the pre-analytical phase proposed by the IFCC WG-LEPS SRRs in the emergency laboratory 
of Hacettepe University (%)
Patient identification
Number of requests with errors concerning patient identification/Total number of requests 0.1
Data entry of the request
Number of requests with errors concerning test input (missing or added or misinterpreted) / 
Total number of requests
1.4
Sample identification
Number of improperly labeled samples / Total number of samples 0.2
Sample collection
Number of samples collected in inappropriate container / Total number of samples 3.6
Number of samples with insufficient sample volume / Total number of samples 22
Transport of sample
Number of damaged samples / Total number of samples 0.2
Number of samples transported at inappropriate time / Total number of samples 3.4
Number of samples transported under inappropriate temperature / Total number of sample 1.2
Number of improperly stored samples / Total number of samples 0.4
Number of samples lost-not received / Total number of samples 0.2
Suitability of sample
Number of samples with inadequate sample-anticoagulant ratio / Total number of samples 34.9
Number of fibrin clotted samples / Total number of samples 27.9
Number of hemolyzed samples / Total number of samples 2.2
Number of lipemic samples / Total number of samples 0.1
Number of samples contaminated by intravenous infusion / Total number of samples 2.2
SRR - sample rejection ratio
emergency department (31%) followed by neurol-
ogy intensive care unit (14%) and internal medi-
cine inpatient service (10%). To more closely exam-
ine this finding, we compared the rejection ratio 
between ICUs, the nonsurgical ICUs (40%) have 
significantly higher rejection rate compared with 
the surgical ICUs (10%) (Figure 1B). The rejection 
rates for neurology ICU (14%) was 2 fold more than 
internal medicine ICU (7%) and 3 fold more than 
surgical ICUs (4.5%), respectively. Evaluation of the 
pediatric samples received from Hacettepe Chil-
dren’s Hospital has shown that pediatric emergen-
cy department (10%) and the newborn service 
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(5%) have the highest rejection rate. Surprisingly, 
the rate of rejected samples from pediatric ED 
(10%) was 3 fold less than adult ED (31%).
The SRRs in our emergency laboratory were 
grouped according to Quality indicators of the 
preanalytical phase proposed by the IFCC Working 
Group - Laboratory Errors and Patient Safety (IFCC 
WG-LEPS) and given in Table 2.
According to one year follow-up of our emergency 
laboratory data, the calculated rejection ratios was 
2.5% for biochemistry tests, 3.2% for CBC, 9.8% for 
blood gases, 9.2% for urine analysis, 13.3% for co-
agulation tests, 12.8% for therapeutic drug moni-
toring, 4.5% for cardiac markers and 11% for hor-
mone tests as shown in Figure 2. 
The most common rejection causes according to 
the test groups were the presence of fibrin clots 
(28%) and insufficient volume (9%) were the most 
frequent causes of rejection of biochemical tests. 
For coagulation tests, blood gas analyses and CBC; 
clotted samples (35%) and inadequate volume 
(13%) were the major causes of rejection.
We also assessed the proportion of rejection by 
the work shifts of the laboratory personnel; the 
proportion of specimen rejections was higher dur-
ing the night shift (66%) compared with the day 
shift (34%), respectively (Figure 3).
Discussion
Identification and documentation of a problem is 
a key step for improving the quality of laboratory 
medicine. We conducted a retrospective study to 
identify the proportions of rejected specimens at 
the emergency laboratory. We detected an overall 
specimen rejection rate of 6% in our emergency 
laboratory. Our results have shown that the most 
important rejection cause in our emergency labo-
ratory is fibrin clots (28%) for biochemistry tests, 
additionally red cell clots (35%) for coagulation 
tests, CBC and blood gas analyses. We observed 
that visible clots, either as a red cell clot in whole 
blood or a fibrin clot in plasma, are usually re-
ceived from intensive care units, emergency de-
partment and newborn premature services. The 
major cause of clotted samples is probably due to 
poor mixing after blood collection and leaving the 
tubes horizontally instead of keeping them verti-
cal. All diagnostic blood specimens collected in 
vacuum tubes are recommended to be inverted 
gently several times by all vacuum tubes manufac-
turers’ datasheets and Clinical Laboratory Stand-
ards Institute (CLSI) documents to maximize the 
contact between blood and additives following 
blood collection (12,13). Parenmark and Landberg 
(14) have shown that mixing blood samples imme-
diately after collection (for 1 min, inverting 15 
times) may not be mandatory and instant mixing 
may produce hemolysis. Based on their outcomes, 
Figure 3. Sample rejection ratios (SRRs) during day shift and 
night shift. 
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Lima-Oliveria et al . (15) compared the impact of 
three different mixing procedures for clinical 
chemistry, hematology, and coagulation parame-
ters a) Gold standard – all specimens were mixed 
gently by five-time inversion b) Rest time – all 
blood specimens remained 5 min at rest in an up-
right position, followed by gently mixing by 5 in-
versions; c) No mix- all blood specimens were left 
in an upright position, without mixing. They ob-
served no fibrin filaments or micro clots in any 
sample concluding that mixing of blood speci-
mens collected with an evacuated tube system 
appears to be unnecessary; probably the blood 
turbulence generated by standard vacuum pres-
sure inside the primary tubes is by itself sufficient 
to provide solubilization, mixing and stabilization 
of additives and blood during venipuncture.
The high incidence of fibrin containing samples 
may be related with the short lag period between 
the blood collection process and centrifugation 
step. The mean time between blood collection 
and centrifugation is usually 10 minutes. To pre-
vent the formation of fibrin, we planned to use 
rapid serum tubes (RST), which accelerates coagu-
lation, reduces sample processing time and in-
creases serum quality, suitable especially for emer-
gency departments and ICUs. To decrease the ra-
tio of clotted blood gas samples due to long trans-
portation routes, several point of care blood gas 
analyzers are set up in ICUs and EDs which are un-
der the control of laboratory specialists. Another 
reason for the high incidence of fibrin clotted sam-
ples may be not using evacuated tube system for 
blood collection. During our visits to inpatient fa-
cilities, we observed that collection of blood by 
the conventional syringe/needle/container system 
is still used in clinical departments. 
Insufficient samples are the second most common 
reason (22%) for sample rejection in our emergen-
cy laboratory. We know the difficulty of collecting 
sufficient blood sample from newborns, children, 
oncology and ICU patients. The performance of 
venipuncture especially in infants and children re-
quires special training and skill. The pediatric pop-
ulation also has a risk for anemia due to frequent 
blood draws necessitating small specimen vol-
umes (16). Thus, microtainers and microtubes are 
preferred for blood collection in pediatric, geriat-
ric, oncology, neonatal intensive care unit patients 
to reduce the sample volume. Additionally, we use 
advanced automated laboratory instruments with 
minimized specimen volumes and dead volume in 
the emergency laboratory. Moreover, insufficient 
samples cause inappropriate blood to anticoagu-
lant ratio, it has been shown that especially coagu-
lation tests such as PT, aPTT, thrombin time are sig-
nificantly longer and fibrinogen levels are signifi-
cantly lower in undefiled samples. Lippi et al. (17) 
have identified a clinically significant bias in test 
results when tubes are drawn at less than 89% of 
total fill for activated partial thromboplastin time 
(aPTT), less than 78% for fibrinogen, and less than 
67% for coagulation factor VIII, whereas prothrom-
bin time (PT) and activated protein C resistance re-
main relatively reliable even in tubes drawn at 67% 
of the nominal volume. Hence, under-filled citrat-
ed tubes containing less than 80% of target vol-
ume failed our acceptance criteria.
For TDM, blood samples in the tubes including se-
rum separator gels are not accepted. The barrier 
gels can absorb some drugs such as phenytoin, 
phenobarbital, lidocaine and carbamazepine as 
demonstrated by the recovery of drugs following 
chemical extraction of the barrier gels with metha-
nol. For this reason, standard blood collection 
tubes without barrier gels are suggested for TDM 
(18). For methotrexate measurement, blood sam-
ples which are not carried on ice and in the dark 
are not accepted to the laboratory. For cyclo-
sporine level monitoring, only whole blood sam-
ples containing EDTA are accepted.
Patient specimen identification errors have been 
reported as one of the leading causes of laborato-
ry errors. Misidentification is associated with the 
worst clinical outcome, due to the potential for 
misdiagnosis and inappropriate medications or 
surgery. This is why the Joint Commission and the 
World Health Organisatin (WHO) Alliance for pa-
tient safety have established that the first goal for 
clinical laboratories should be to “improve patient 
and sample identification” (19). In Hacettepe Uni-
versity hospitals, identification wristbands (name 
and surname, birthdate, and patient identification 
number) are used at inpatient units to prevent 
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wrong medication and wrong site surgery. At the 
same time, electronic barcoding system is used for 
identification of patients, specimens and laborato-
ry testing and test result reporting. Before a clini-
cal specimen is accepted to emergency laboratory, 
laboratory secretary make sure that the minimum 
two criteria for sample identification (name, sur-
name and patient ID) are met, additionally check 
whether the sample and test requests match cor-
rectly. As a result of this, our misidentification ratio 
is only 0.3%. It has been shown that barcoding 
practices are effective at reducing patient specimen 
and laboratory testing identification errors which 
can cause adverse patient outcomes, therefore rec-
ommended as an ‘evidence-based best practice’ 
(20). However, from time to time, we observed that 
barcode scanners may misread patient identifica-
tion barcodes due to incompatibility between the 
barcode print area sizes or symbology on patient ID 
bands or specimen labels with scanner settings. 
Bonini et al. (21) reported that a higher proportion 
of specimens that were collected at either inpa-
tient services or emergency department locations 
were rejected primarily because of hemolysis. 
Lowe et al. (22) have shown that blood draws from 
indwelling catheters or during IV starts is more 
prone to hemolysis compared to venipuncture 
draws. The ratio of hemolytic samples was 2% and 
samples contaminated with IV infusion 2.2% in our 
emergency laboratory. We are aware that blood 
samples collected through an intravenous cathe-
ter by some of our medical staff working at the ED 
and inpatient services increase hemolysis due to 
flow through the narrow tube. Sheppard et al. (23) 
reported that when the phlebotomy was per-
formed in an emergency department by dedicat-
ed laboratory technologists, there was a reduction 
in overall TAT and blood culture contamination 
rates. Therefore, the number of professional phle-
botomy teams working in shifts needs to be in-
creased in Hacettepe University Hospitals. 
Urinalysis is highly susceptible to preanalytical 
problems as urine samples are collected by pa-
tients. To improve the reliability of urine testing, 
laboratory secretary inform the patients about 
sampling, container types (sterile, with/without 
preservatives) and collection of the midstream 
urine sample. Despite this, incorrect urine collec-
tion is still high (9.2%) in our hospital.
Preanalytical errors are largely related with the 
procedures performed outside the laboratory by 
healthcare personnel who are not under the con-
trol of clinical laboratory but the majority of these 
errors are preventable. To achieve a high degree of 
total quality in the preanalytical phase; error pre-
vention, error detection, and error management 
are the most critical points for laboratory special-
ists (24-26). Due to continuous staff turnover in 
services and inadequate training, the ratio of spec-
imen collection into inappropriate containers is 
3.6% in our institute. For example, sending cere-
brospinal fluid sample in a urine cap instead of 
special sterile cerebrospinal fluid tube is a com-
mon mistake especially observed in neurology 
ICU. For such situations, an additional biological 
specimen is requested which threatens patient 
safety. Lillo R. et al. (27) have published that effec-
tive improvements in the preanalytical phase can 
be achieved by periodic educational improvement 
of the healthcare personnel by laboratory special-
ists. Thus, we started comprehensive education 
seminars every 2 months for healthcare personnel 
(residents, intern doctors, nurses) especially those 
working in EDs and ICUs related about venipunc-
ture techniques, adequate tourniquet application, 
use of appropriate tubes with additives, order of 
tubes, gentle mixing and transport. 
The most commonly reported types of preanalyti-
cal errors in the stat laboratory were hemolyzed 
samples (46.4% in biochemistry), clotted samples 
(43.2% in hematology), lost samples (6.4%), inade-
quate sample-anticoagulant ratio (2.9%), patient 
misidentification (0.7%), samples collected in 
wrong blood collection tubes (0.3%) and missing 
test requests (0.1%) (11). We have previously re-
ported the sample rejection ratios of our core lab-
oratory; the most frequent reason was the clotted 
specimen (55.8% of total rejections), followed by 
inadequate volume (29.3% of total rejections), sim-
ilar to the emergency laboratory data. Most of the 
clotted specimens were received from adult hos-
pital inpatient services (54.3%), followed by pedi-
atric hospital inpatient services (26.8%) (28).
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Sample rejection prevents sample analysis and 
leads to new sample request, which prolongs the 
TAT and cause the delay in diagnosis and treat-
ment of critical patients, leading to adverse pa-
tient outcomes (29-31). Unfortunately, it is not easy 
to standardize all of the preanalytical processes 
and there are still no universally accepted guide-
lines for management of unacceptable specimens 
(32). This study has shown the most frequent caus-
es of pre-preanalytical errors and sample rejection 
rates that are observed in the emergency labora-
tory of Hacettepe University Hospitals. We planned 
to improve the patient outcomes by reducing our 
SRRs from 6% to below 2%. For this purpose, we 
started enhanced documentation of rejected sam-
ples monthly and organize periodic training for 
healthcare personnel working in the departments 
with high rates of rejection. We believe that receiv-
ing sufficient amount of the sample collected un-
der appropriate conditions in suitable containers 
will enhance the reliability of laboratory test re-
sults, prevent turnaround delay, and improve the 
patient outcome. Within 2014, our institution has 
achieved Joint Commission International (JCI) ac-
creditation which works for improvement in quali-
ty and patient safety. 
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